Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Sex as a Biological Variable: Who, What, When, Why, and How.

Bale TL, Epperson CN.

Neuropsychopharmacology. 2017 Jan;42(2):386-396. doi: 10.1038/npp.2016.215. Epub 2016 Sep 23. Review.

PMID:
27658485
2.

From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia.

Cariaga-Martinez A, Saiz-Ruiz J, Alelú-Paz R.

Front Neurosci. 2016 May 11;10:202. doi: 10.3389/fnins.2016.00202. eCollection 2016. Review.

3.

Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History.

Greenwood TA, Light GA, Swerdlow NR, Calkins ME, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Freedman R, Braff DL.

Am J Psychiatry. 2016 Apr 1;173(4):385-91. doi: 10.1176/appi.ajp.2015.15050605. Epub 2015 Oct 6.

4.

Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.

Light GA, Swerdlow NR.

Ann N Y Acad Sci. 2015 May;1344:105-19. doi: 10.1111/nyas.12730. Epub 2015 Mar 9. Review.

5.

Oxytocin and social cognition in affective and psychotic disorders.

Mercedes Perez-Rodriguez M, Mahon K, Russo M, Ungar AK, Burdick KE.

Eur Neuropsychopharmacol. 2015 Feb;25(2):265-82. doi: 10.1016/j.euroneuro.2014.07.012. Epub 2014 Aug 1. Review.

6.

Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study.

Light G, Greenwood TA, Swerdlow NR, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Bull. 2014 Nov;40(6):1404-11. doi: 10.1093/schbul/sbu064. Epub 2014 Jun 5.

7.

CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study.

Clemm von Hohenberg C, Wigand MC, Kubicki M, Leicht G, Giegling I, Karch S, Hartmann AM, Konte B, Friedl M, Ballinger T, Eckbo R, Bouix S, Jäger L, Shenton ME, Rujescu D, Mulert C.

J Psychiatr Res. 2013 Oct;47(10):1349-56. doi: 10.1016/j.jpsychires.2013.07.002. Epub 2013 Jul 17.

8.

Iron deficiency with or without anemia impairs prepulse inhibition of the startle reflex.

Pisansky MT, Wickham RJ, Su J, Fretham S, Yuan LL, Sun M, Gewirtz JC, Georgieff MK.

Hippocampus. 2013 Oct;23(10):952-62. doi: 10.1002/hipo.22151. Epub 2013 Jul 8.

9.

Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Kocsis B, Brown RE, McCarley RW, Hajos M.

CNS Neurosci Ther. 2013 Jun;19(6):437-47. doi: 10.1111/cns.12081. Epub 2013 Apr 24. Review.

10.

A diagnostic model incorporating P50 sensory gating and neuropsychological tests for schizophrenia.

Shan JC, Liu CM, Chiu MJ, Liu CC, Chien YL, Hwang TJ, Lin YT, Hsieh MH, Jaw FS, Hwu HG.

PLoS One. 2013;8(2):e57197. doi: 10.1371/journal.pone.0057197. Epub 2013 Feb 27.

11.

Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease.

Takahashi H, Hashimoto R, Iwase M, Ishii R, Kamio Y, Takeda M.

Clin Psychopharmacol Neurosci. 2011 Dec;9(3):102-10. doi: 10.9758/cpn.2011.9.3.102. Epub 2011 Dec 31.

12.

Biomarkers of Alzheimer's disease among Mexican Americans.

O'Bryant SE, Xiao G, Edwards M, Devous M, Gupta VB, Martins R, Zhang F, Barber R; Texas Alzheimer's Research and Care Consortium (TARCC).

J Alzheimers Dis. 2013;34(4):841-9. doi: 10.3233/JAD-122074.

13.

Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia.

Light GA, Swerdlow NR, Rissling AJ, Radant A, Sugar CA, Sprock J, Pela M, Geyer MA, Braff DL.

PLoS One. 2012;7(7):e39434. doi: 10.1371/journal.pone.0039434. Epub 2012 Jul 3.

14.

Association analysis of 94 candidate genes and schizophrenia-related endophenotypes.

Greenwood TA, Light GA, Swerdlow NR, Radant AD, Braff DL.

PLoS One. 2012;7(1):e29630. doi: 10.1371/journal.pone.0029630. Epub 2012 Jan 13.

15.

Variants of the RELA gene are associated with schizophrenia and their startle responses.

Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Yamamori H, Takahashi H, Iwase M, Okochi T, Kazui H, Saitoh O, Tatsumi M, Iwata N, Ozaki N, Kamijima K, Kunugi H, Takeda M.

Neuropsychopharmacology. 2011 Aug;36(9):1921-31. doi: 10.1038/npp.2011.78. Epub 2011 May 18.

16.

Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Gandal MJ, Edgar JC, Klook K, Siegel SJ.

Neuropharmacology. 2012 Mar;62(3):1504-18. doi: 10.1016/j.neuropharm.2011.02.007. Epub 2011 Feb 22. Review.

17.

Cognitive control deficits in schizophrenia: mechanisms and meaning.

Lesh TA, Niendam TA, Minzenberg MJ, Carter CS.

Neuropsychopharmacology. 2011 Jan;36(1):316-38. doi: 10.1038/npp.2010.156. Epub 2010 Sep 15. Review.

18.

Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation.

Cheung C, Yu K, Fung G, Leung M, Wong C, Li Q, Sham P, Chua S, McAlonan G.

PLoS One. 2010 Aug 18;5(8):e12233. doi: 10.1371/journal.pone.0012233.

19.

Reduced multisensory integration in patients with schizophrenia on a target detection task.

Williams LE, Light GA, Braff DL, Ramachandran VS.

Neuropsychologia. 2010 Aug;48(10):3128-36. doi: 10.1016/j.neuropsychologia.2010.06.028. Epub 2010 Jun 26.

20.

Electroencephalography (EEG) and event-related potentials (ERPs) with human participants.

Light GA, Williams LE, Minow F, Sprock J, Rissling A, Sharp R, Swerdlow NR, Braff DL.

Curr Protoc Neurosci. 2010 Jul;Chapter 6:Unit 6.25.1-24. doi: 10.1002/0471142301.ns0625s52.

Supplemental Content

Support Center